dc.contributor.author | Regev, Aviv | |
dc.date.accessioned | 2020-05-06T12:09:14Z | |
dc.date.available | 2020-05-06T12:09:14Z | |
dc.date.issued | 2018-07 | |
dc.identifier.issn | 0022-1007 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/125033 | |
dc.description.abstract | A number of autoimmunity-associated MHC class II proteins interact only weakly with the invariant chain-derived class II-associated invariant chain peptide (CLIP). CLIP dissociates rapidly from I-Ag7 even in the absence of DM, and this property is related to the type 1 diabetes-associated β57 polymorphism. We generated knock-in non-obese diabetic (NOD) mice with a single amino acid change in the CLIP segment of the invariant chain in order to moderately slow CLIP dissociation from I-Ag7 These knock-in mice had a significantly reduced incidence of spontaneous type 1 diabetes and diminished islet infiltration by CD4 T cells, in particular T cells specific for fusion peptides generated by covalent linkage of proteolytic fragments within β cell secretory granules. Rapid CLIP dissociation enhanced the presentation of such extracellular peptides, thus bypassing the conventional MHC class II antigen-processing pathway. Autoimmunity-associated MHC class II polymorphisms therefore not only modify binding of self-peptides, but also alter the biochemistry of peptide acquisition. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grant P01AI045757) | en_US |
dc.language.iso | en | |
dc.publisher | Rockefeller University Press | en_US |
dc.relation.isversionof | 10.1084/JEM.20180300 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-Share Alike | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | en_US |
dc.source | Rockefeller University Press | en_US |
dc.title | Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Ito, Yoshinaga et al. “Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity.” Journal of experimental medicine 215 (2018): 2617-2635 © 2018 The Author(s) | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.relation.journal | Journal of experimental medicine | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2020-01-28T18:09:28Z | |
dspace.date.submission | 2020-01-28T18:09:30Z | |
mit.journal.volume | 215 | en_US |
mit.journal.issue | 10 | en_US |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Complete | |